These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 28276310)

  • 1. Basic Transcription Factor 3 Is Required for Proliferation and Epithelial-Mesenchymal Transition via Regulation of FOXM1 and JAK2/STAT3 Signaling in Gastric Cancer.
    Zhang DZ; Chen BH; Zhang LF; Cheng MK; Fang XJ; Wu XJ
    Oncol Res; 2017 Nov; 25(9):1453-1462. PubMed ID: 28276310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Basic transcription factor 3 is involved in gastric cancer development and progression.
    Liu Q; Zhou JP; Li B; Huang ZC; Dong HY; Li GY; Zhou K; Nie SL
    World J Gastroenterol; 2013 Jul; 19(28):4495-503. PubMed ID: 23901224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial ROS accumulation inhibiting JAK2/STAT3 pathway is a critical modulator of CYT997-induced autophagy and apoptosis in gastric cancer.
    Cao Y; Wang J; Tian H; Fu GH
    J Exp Clin Cancer Res; 2020 Jun; 39(1):119. PubMed ID: 32576206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pterostilbene suppresses gastric cancer proliferation and metastasis by inhibiting oncogenic JAK2/STAT3 signaling: In vitro and in vivo therapeutic intervention.
    He P; Li Y; Hu J; Deng B; Tan Z; Chen Y; Yu B; Dong W
    Phytomedicine; 2024 Jun; 128():155316. PubMed ID: 38518635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DC-SIGN mediates gastric cancer progression by regulating the JAK2/STAT3 signaling pathway and affecting LncRNA RP11-181G12.2 expression.
    Li X; Na H; Xu L; Zhang X; Feng Z; Zhou X; Cui J; Zhang J; Lin F; Yang S; Yue F; Mousa H; Zuo Y
    Biomed Pharmacother; 2020 Jan; 121():109644. PubMed ID: 31766099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. STAT3 interacts with Skp2/p27/p21 pathway to regulate the motility and invasion of gastric cancer cells.
    Wei Z; Jiang X; Qiao H; Zhai B; Zhang L; Zhang Q; Wu Y; Jiang H; Sun X
    Cell Signal; 2013 Apr; 25(4):931-8. PubMed ID: 23333463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knockdown of TRIM66 inhibits cell proliferation, migration and invasion in colorectal cancer through JAK2/STAT3 pathway.
    He T; Cui J; Wu Y; Sun X; Chen N
    Life Sci; 2019 Oct; 235():116799. PubMed ID: 31472144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. STAM2 knockdown inhibits proliferation, migration, and invasion by affecting the JAK2/STAT3 signaling pathway in gastric cancer.
    Yang Y; Zhang Q; Liang J; Yang M; Wang Z; Tang D; Wang D
    Acta Biochim Biophys Sin (Shanghai); 2021 May; 53(6):697-706. PubMed ID: 33778841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acylglycerol kinase promotes paclitaxel resistance in nasopharyngeal carcinoma cells by regulating FOXM1 via the JAK2/STAT3 pathway.
    Zhao C; Chen HY; Zhao F; Feng HJ; Su JP
    Cytokine; 2021 Dec; 148():155595. PubMed ID: 34116927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
    Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C
    World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of FoxM1 leads to the inhibition of the epithelial-mesenchymal transition in gastric cancer cells.
    Miao L; Xiong X; Lin Y; Cheng Y; Lu J; Zhang J; Cheng N
    Cancer Genet; 2014 Mar; 207(3):75-82. PubMed ID: 24726291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-6 secreted by cancer-associated fibroblasts promotes epithelial-mesenchymal transition and metastasis of gastric cancer via JAK2/STAT3 signaling pathway.
    Wu X; Tao P; Zhou Q; Li J; Yu Z; Wang X; Li J; Li C; Yan M; Zhu Z; Liu B; Su L
    Oncotarget; 2017 Mar; 8(13):20741-20750. PubMed ID: 28186964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-630 Suppresses Epithelial-to-Mesenchymal Transition by Regulating FoxM1 in Gastric Cancer Cells.
    Feng J; Wang X; Zhu W; Chen S; Feng C
    Biochemistry (Mosc); 2017 Jun; 82(6):707-714. PubMed ID: 28601080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytoplasmic p27 promotes epithelial-mesenchymal transition and tumor metastasis via STAT3-mediated Twist1 upregulation.
    Zhao D; Besser AH; Wander SA; Sun J; Zhou W; Wang B; Ince T; Durante MA; Guo W; Mills G; Theodorescu D; Slingerland J
    Oncogene; 2015 Oct; 34(43):5447-59. PubMed ID: 25684140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knockdown of CMTM3 promotes metastasis of gastric cancer via the STAT3/Twist1/EMT signaling pathway.
    Yuan W; Li T; Mo X; Wang X; Liu B; Wang W; Su Y; Xu L; Han W
    Oncotarget; 2016 May; 7(20):29507-19. PubMed ID: 27121055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. α-Hederin inhibits interleukin 6-induced epithelial-to-mesenchymal transition associated with disruption of JAK2/STAT3 signaling in colon cancer cells.
    Sun D; Shen W; Zhang F; Fan H; Xu C; Li L; Tan J; Miao Y; Zhang H; Yang Y; Cheng H
    Biomed Pharmacother; 2018 May; 101():107-114. PubMed ID: 29477470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BTF3 promotes proliferation and glycolysis in hepatocellular carcinoma by regulating GLUT1.
    Wang P; Sun J; Sun C; Zhao H; Zhang Y; Chen J
    Cancer Biol Ther; 2023 Dec; 24(1):2225884. PubMed ID: 37382415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding RNA FEZF1-AS1 promotes cell invasion and epithelial-mesenchymal transition through JAK2/STAT3 signaling pathway in human hepatocellular carcinoma.
    Wang YD; Sun XJ; Yin JJ; Yin M; Wang W; Nie ZQ; Xu J
    Biomed Pharmacother; 2018 Oct; 106():134-141. PubMed ID: 29957463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BTF3-mediated regulation of BMI1 promotes colorectal cancer through influencing epithelial-mesenchymal transition and stem cell-like traits.
    Zhou W; Yun Z; Wang T; Li C; Zhang J
    Int J Biol Macromol; 2021 Sep; 187():800-810. PubMed ID: 34293363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting FoxM1 inhibits proliferation, invasion and migration of nasopharyngeal carcinoma through the epithelial‑to-mesenchymal transition pathway.
    Yu C; Chen L; Yie L; Wei L; Wen T; Liu Y; Chen H
    Oncol Rep; 2015 May; 33(5):2402-10. PubMed ID: 25738652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.